Metroplex Clinical Research Center
Dallas, Texas, United States
Research institute in Dallas, Texas
8144 Walnut Hl Ln # 810, Dallas, TX 75231
About Metroplex Clinical Research Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Metroplex Clinical Research Center
During the past decade, Metroplex Clinical Research Center conducted 53 clinical trials. In the 10-year time frame, 53 clinical trials started and 47 clinical trials were completed, i.e. on
average, 88.7% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 22 clinical trials were completed. i.e. 129.4%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung Cancer
2001-03-01
2008-11-01
Completed
S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck Cancer
2006-04-01
Unknown status
500
Implant Radiation Therapy Using Radioactive Iodine in Treating Patients With Localized Prostate Cancer
2005-07-01
2021-12-13
Completed
6,927
Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer
2009-02-04
2018-06-03
Completed
233
Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer
2009-07-09
2019-10-04
Completed
2,840
A Phase 2 Study Comparing TAS-102 Versus Topotecan or Amrubicin to Treat Small Cell Lung Cancer Following Platinum-Based Chemotherapy
2013-07-01
2014-06-01
Terminated
18
Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer
2014-01-01
2019-12-01
Completed
310
A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130)
2015-06-23
2021-08-31
Completed
902
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Metroplex Clinical Research Center" #1 sponsor was "Pfizer" with 18 trials, followed by "Eli Lilly and Company" with 7 trials
sponsored, "Bristol-Myers Squibb" with 5 trials sponsored, "Genentech, Inc." with 5 trials sponsored and "Hoffmann-La Roche"
with 5 trials sponsored. Other sponsors include 50 different institutions and
companies that sponsored additional 44 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Metroplex Clinical Research Center"
#1 collaborator was "Incyte Corporation" with 4 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 3 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "California Institute for Regenerative Medicine (CIRM)" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were
collaborators in the rest 24 trials.
Clinical Trials Conditions at Metroplex Clinical Research Center
According to Clinical.Site data, the most researched conditions in "Metroplex Clinical Research Center" are
"Rheumatoid Arthritis" (33 trials), "Systemic Lupus Erythematosus" (13 trials), "Arthritis, Rheumatoid" (7 trials), "Osteoarthritis" (6 trials) and "Lupus Erythematosus, Systemic" (5 trials). Many other conditions were trialed in "Metroplex Clinical Research Center" in a lesser frequency.
Clinical Trials Intervention Types at Metroplex Clinical Research Center
Most popular intervention types in "Metroplex Clinical Research Center" are "Drug" (79 trials), "Biological" (18 trials), "Other" (12 trials), "Device" (3 trials) and "Genetic" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (39 trials), "Baricitinib" (8 trials), "Methotrexate" (8 trials), "Adalimumab" (5 trials) and "Abatacept" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Metroplex Clinical Research Center
The vast majority of trials in "Metroplex Clinical Research Center" are
94 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Metroplex Clinical Research Center
Currently, there are NaN active trials in "Metroplex Clinical Research Center".
undefined are not yet recruiting,
9 are recruiting,
4 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 66 completed trials in Metroplex Clinical Research Center,
undefined suspended trials,
and 12 terminated clinical trials to date.
Out of the total trials that were conducted in Metroplex Clinical Research Center, 22 "Phase 1"
clinical trials were conducted, 24 "Phase 2" clinical
trials and 39 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 9 trials, and there were
also 2 trials that are defined as “Not Applicable".